Women’s Health Diagnostics Market Size, Share, Industry Trends, 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Women’s Health Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global women’s health diagnostics market size, growth, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Industry Overview of Women’s Health Diagnostics

Women’s health diagnostics aid in the diagnosis of diverse biological and psychosocial conditions in female patients, covering aspects such as sexual and vaginal concerns, pregnancy complications, and the management of serious ailments like osteoporosis, menopause, breast cancer, and cervical cancer. These diagnostics depend on an array of advanced laboratory tests, tools, and procedures, encompassing biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Presently, numerous healthcare diagnostics centers provide an extensive selection of laboratory testing solutions, aiming to improve the diagnosis and treatment of rare disorders and conditions that specifically impact women.

How Big Is the Women’s Health Diagnostics Market?

The global women’s health diagnostics market size reached US$ 23.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 37.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.51% during 2023-2028. 

Request Sample Copy of This Report: https://www.imarcgroup.com/womens-health-diagnostics-market/requestsample

What are the growth prospects and trends in the women’s health diagnostics industry?

The market is being positively influenced by the increasing prevalence of health issues that impact the overall well-being of women. Additionally, the global demand for point-of-care (POC) women’s health diagnostics is being catalyzed by the growing health consciousness and rising awareness regarding the advantages of early diagnosis.

Moreover, the need for women’s health diagnostics is driven by the escalating rate of infertility due to stressful lifestyles, alcohol, and drug consumption, with a focus on addressing pregnancy complications and promoting a healthier life. Furthermore, the market is experiencing growth due to a significant rise in the female population aged over 50 years, as menopause increases the risk of developing certain medical conditions, like cardiovascular diseases and urinary incontinence.

Moreover, research studies have highlighted that women are more prone to psychiatric disorders like depression and anxiety during hormonal changes, and the market is benefiting from initiatives undertaken by health agencies in various countries to enhance women’s mental health.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

• Diagnostic Devices
  • Biopsy Device
  • Imaging and Monitoring Devices
  • Accessories and Consumables
• Diagnostic Tests
  • Breast Cancer Testing
  • PAP Smear and HPV Test
  • Pregnancy Testing and Ovulation Testing
  • Others 

Breakup by Application:

• Breast Cancer
• Infectious Disease Testing
• Osteoporosis Testing
• Pregnancy and Fertility Testing
• Sexually Transmitted Disease Testing
• Others

Breakup by End User:

• Hospital and Diagnostics Centers
• Home Care

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/